European Projects

  • “MRC iCASE Leadership, University of Manchester, UK, 100.000 £, 2020-2023”
  • NIHR i4i-connect, DeepMed in collaboration with University of Manchester, UK, 150.000 £, 2019
  • “Deep Learning powered Metastases Detection System for Digital Pathology”, Funded by Small Business Research Initiative (SBRI) Healthcare Challenge on Cancer του NHS UK with1.000.000 £, 2019
  • “Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network (SYNTRAIN)”, Innovative Training Networks (ITN), Funded by EC, Horizon 2020, with 227987 Euros, Project code 722729, 2016-2020
  • “INtegrating the emerging research Potential of the University of Athens Cancer Research Group in the European research area (INsPiRE)”, Funded by EC, FP7, with 2.500.000 Euros, Project code 284460, 2011-2014
  • “Inflammation and Cancer (INFLA-CARE)” Funded by EC, FP7, with 380.000 Euros, 2008-2010
  • “Genomic Instability in Cancer and Precancer (GENICA)” Funded by EC, FP7 with 360.000 Euros, project code 201630, 2008-2010
  • "Gene therapy in Cystic Fibrosis: Expression of CFTR gene by human artificial chromosomes" Funded by GSRT with 78.000 Euros, "ENTER" prorgam, project code SARG 70/3/8660, 2006-2007
  • "Study of the deregulation of DNA licensing factors, the activation of DNA Damage response and their relation with kinetic parameters and ploidy in Non-Small Cell Lung Cancer" Funded by GSRT with 138.480 Euros, "PENED 2003" program, project code 5325/10.05.2004
  • "Study of the changes in the genetic locus KIP2/CDKN1C and its expression in Non-Small Cell Lung Cancer" Funded by the EPEAK, Greek Ministry of Education with 100.000 Euros, "Pythagoras II" program, project code: 70/3/7953 SARG, 2005-2006
  • "Study of the effect of genotoxic agents on the survival of colon cancer cell lines, emphasis on the E2F1–dependent apoptosis" Funded by the EPEAK, Greek Ministry of Education with 100.000 Euros, "Pythagoras II" program, project code 70/3/7952 SARG, 2005-2006
  • "Sensitivity of cancer cells to chemotherapeutic drugs affecting the microtubule integrity: molecular mechanisms related to the expression of the oncosuppressive protein p53 and the oncogene c-mos" Funded by the EPEAK, Greek Ministry of Education with 30.000 Euros, "Heraklitos" program, project code 70/3/7211, 2005
  • “Improvement of Prevention Diagnosis and Treatment of sarcoidosis and Crohn’s disease (SACROHN)”. Funded by the EC, Framework Program 5, with 250.000 Euros, 2000-2002, SARG-NKUA project code 70/3/5394. Co-Investigator
  • “Improvement of Salmonella control in animal feeds based on the molecular and biochemical analysis of the product” funded by EC, FP4 through the CRAFT mechanism, with 500.000 drachmas, 1997

VG New

Prof. Vassilis G. Gorgoulis

Laboratory of Histology-Embryology
Molecular Carcinogenesis Group
Medical School
National and Kapodistrian University of Athens

 

 

Chair of Clinical Molecular Pathology,

Ninewells Hospital and School of Medicine

 

University of Dundee, Dundee, UK

 

Biomedical Research Foundation of the Academy of Athens

 

Faculty Institute for Cancer Sciences, University of Manchester,
Manchester Academic Health Science Centre, Manchester, UK

Manchester Centre for Cellular Metabolism,
University of Manchester, Manchester Academic Health Science Centre, Manchester

 

EMBO member

 

European Academy
of Cancer Sciences member

 

Academia Europaea member

 

Intelligencia.ai, 180 Varick Street, 6th Floor, New York, NY 10014, USA 

 

SenTraGorΤΜ

 

 

 

Office Tel: 0030 210-7462352
Fax: 0030 210-7462340
E-mail: vgorg@med.uoa.gr

News

Error: No articles to display

Also see...

Newsletters

Copyright ©2011-2015, Prof. Gorgoulis Powered by AVMap